Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: A 12-month, double-blind, parallel clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 9, 2007, Pages 3446-3452

  Calaf, Joaquim ^a   Lopez E ^b   Millet, A ^c   Alcaniz J ^d   Fortuny, A ^e   Vidal, O ^f   Callejo, J ^g   Escobar Jimenez F ^h   Torres, E ^h   Espinos J J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g HOSPITAL SANT JOAN DE DÉU   (Spain)

^h HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; FLUTAMIDE; HORMONE; PLACEBO;

ACNE; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANALYSIS OF VARIANCE; APPENDICITIS; ARTICLE; AUTONOMIC NEUROPATHY; BRONCHOPNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; FEMALE; FISHER EXACT TEST; FLU LIKE SYNDROME; FRIEDMAN TEST; GASTROINTESTINAL DISEASE; HEADACHE; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SEBORRHEA; SIDE EFFECT; SKIN DISEASE; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 34548799898     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2798     Document Type: Article

References (32)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
2. Knochenhauer ES, Azziz R 1995 Advances in the diagnosis and treatment of the hirsute patient. Curr Opin Obstet Gynecol 7:344-350
3. Azziz R, Carmina E, Sawaya ME 2000 Idiopathic Hirsutism. Endocr Rev 21:347-362
4. Rosenfield RL 2005 Hirsutism. N Engl J Med 353:2578-2588
5. Hunter MH, Carek PJ 2003 Evaluation and treatment of women with hirsutism. Am Fam Physician 67:2565-2572
6. Moghetti P, Toscano V 2006 Treatment of hirsutism and acne in hyperandrogenism. Best Pract Res Clin Endocrinol Metabol 20:221-234
7. Nader S, Diamanti-Kandarakis E 2007 Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod 22:317-322
8. Couzinet B, Pholsena M, Young J, Schaison G 1993 The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol (Oxf) 39:157-162
9. Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R 1996 Changes in androgens during treatment with four low-dose contraceptives. Contraception 53:171-176
10. Cusan L, Dupont A, Belanger A, Tremblay RR, Manhes G, Labrie F 1990 Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 23:462-469
11. Motta T, Maggi G, Perra M, Azzolari E, Casazza S, D'Alberton A 1991 Flutamide in the treatment of hirsutism. Int J Gynaecol Obstet 36:155-157
12. Marcondes JA, Minnani SL, Luthold WW, Wajchenberg BL, Samojlik E, Kirschner MA 1992 Treatment of hirsutism in women with flutamide. Fertil Steril 57:543-547
13. Moghetti P, Castello R, Negri C, Tosi F, Magnani CM, Fontanarosa MC, Armanini D, Muggeo M 1995 Flutamide in the treatment of hirsutism: longterm clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 64:511-517
14. Wysowski DK, Freiman JP, Tourtelot JB, Horton 3rd ML 1993 Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 118:860-864
15. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
16. Cremoncini C, Vignati E, Libroia A 1976 Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. Acta Eur Fertil 7:299-314
17. Lemay A, Dewailly SD, Grenier R, Huard J 1990 Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. J Clin Endocrinol Metab 71:8-14
18. Spritzer PM, Lisboa Ko, Matiello S, Lhullier F 2000 Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol (Oxf) 52:587-594
19. Erenus M, Gurbuz O, Durmusoglu F, Demircay Z, Pekin S 1994 Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 61:613-616
20. Cusan L, Dupont A, Gomez JL, Tremblay RR, Labrie F 1994 Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril 61:281-287
21. Falsetti L, Gambera A 1999 Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism. Fertil Steril 72:41-46
22. Falsetti L, Gambera A, Legrenzi L, Iacobello C, Bugari G 1999 Comparison of finasteride versus flutamide in the treatment of hirsutism. Eur J Endocrinol 141:361-367
23. Muderris II, Bayram F, Sahin Y, Kelestimur F 1997 A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism. Fertil Steril 68:644-647
24. Muderris, II, Bayram F 1999 Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 22:165-168
25. Muderris II, Bayram F, Guven M 2000 A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 73:984-987
26. Muderris II, Bayram F, Guven M 2000 Treatment of hirsutism with lowestdose flutamide (62.5 mg/day). Gynecol Endocrinol 14:38-41
27. De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A 2000 Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. Gynecol Endocrinol 14:411-416
28. Moghetti P, Tosi F, Tosti A, Negri C, Misciali C, Perrone F, Caputo M, Muggeo M, Castello R 2000 Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 85:89-94
29. De Leo V, La Marca, A, Lanzetta D, Cariello PL, D'Antona D, Morgante G 1998 Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF). Clin Endocrinol (Oxf) 49:85-89
30. Vrbíková J, Hill M, Dvorákova K, Stanická S, Vondra K, Stárka L 2004 Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome. Gynecol Obstet Invest 58:36-41
31. Dourakis SP, Alexopoulou AA, Hadziyannis SJ 1994 Fulminant hepatitis after flutamide treatment. J Hepatol 20:350-353
32. Garcia Cortes M, Andrade RJ, Lucena MI, Sanchez Martinez H, Fernandez MC, Ferrer T, Martin-Vivaldi R, Pelaez G, Suarez F, Romero-Gomez M, Montero JL, Fraga E, Camargo R, Alcantara R, Pizarro MA, Garcia-Ruiz E, Rosemary-Gomez M 2001 Flutamide-induced hepatotoxicity: report of a case series. Rev Esp Enferm Dig [Erratum (2001) 93:634] 93:423-432